Judith A Reinsdorf - Net Worth and Insider Trading

Judith A Reinsdorf Net Worth

The estimated net worth of Judith A Reinsdorf is at least $9 Million dollars as of 2023-10-01. Judith A Reinsdorf is the EVP and General Counsel of Tyco International PLC and owns about 190,237 shares of Tyco International PLC (TYC) stock worth over $9 Million. Details can be seen in Judith A Reinsdorf's Latest Holdings Summary section.

Transaction Summary of Judith A Reinsdorf


Judith A Reinsdorf Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Judith A Reinsdorf owns 5 companies in total, including Alexion Pharmaceuticals Inc (ALXN) , Johnson Controls International PLC (JCI) , and Cornerstone Building Brands Inc (CNR) among others .

Click here to see the complete history of Judith A Reinsdorf’s form 4 insider trades.

Insider Ownership Summary of Judith A Reinsdorf

Ticker Comapny Transaction Date Type of Owner
ALXN Alexion Pharmaceuticals Inc 2020-05-14 director
JCI Johnson Controls International PLC 2007-06-29 EVP and General Counsel
CNR Cornerstone Building Brands Inc 2022-07-25 director
NPO EnPro Industries Inc 2021-09-01 director
NRIX Nurix Therapeutics Inc 2021-10-01 director

Judith A Reinsdorf Latest Holdings Summary

Judith A Reinsdorf currently owns a total of 1 stock. Judith A Reinsdorf owns 190,237 shares of Tyco International PLC (TYC) as of August 12, 2015, with a value of $9 Million.

Latest Holdings of Judith A Reinsdorf

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
TYC Tyco International PLC 2015-08-12 190,237 45.59 8,672,905

Holding Weightings of Judith A Reinsdorf

Judith A Reinsdorf Form 4 Trading Tracker

According to the SEC Form 4 filings, Judith A Reinsdorf has made a total of 0 transactions in Tyco International PLC (TYC) over the past 5 years. The most-recent trade in Tyco International PLC is the sale of 111,026 shares on August 12, 2015, which brought Judith A Reinsdorf around $4 Million.

Insider Trading History of Judith A Reinsdorf

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Judith A Reinsdorf Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Judith A Reinsdorf Ownership Network

Ownership Network List of Judith A Reinsdorf

No Data

Ownership Network Relation of Judith A Reinsdorf

Judith A Reinsdorf Owned Company Details

What does Alexion Pharmaceuticals Inc do?

Alexion Pharmaceuticals specializes in developing and marketing drugs for rare, life-threatening medical conditions. Its blockbuster product, Soliris, is approved for paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), generalized myasthenia gravis (gMG), and neuromyelitis optica spectrum disorder (NMOSD). Next-generation Ultomiris is approved in PNH and aHUS. Strensiq and Kanuma target ultrarare metabolic diseases. Alexion's pipeline targets rare diseases with high unmet need in hematology, nephrology, metabolic diseases, neurology, cardiology, and other areas.

Who are the key executives at Alexion Pharmaceuticals Inc?

Judith A Reinsdorf is the director of Alexion Pharmaceuticals Inc. Other key executives at Alexion Pharmaceuticals Inc include EVP & Chief Commercial Officer Brian Goff , EVP & Research & Development John J Orloff , and EVP & Chief Compliance Officer Indrani Lall Franchini .

Alexion Pharmaceuticals Inc (ALXN) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Alexion Pharmaceuticals Inc (ALXN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Alexion Pharmaceuticals Inc (ALXN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Alexion Pharmaceuticals Inc (ALXN)'s detailed insider trading history can be found in Insider Trading Tracker table.


Alexion Pharmaceuticals Inc Insider Transactions

No Available Data

Judith A Reinsdorf Mailing Address

Above is the net worth, insider trading, and ownership report for Judith A Reinsdorf. You might contact Judith A Reinsdorf via mailing address: C. R. Bard, Inc., 730 Central Avenue, Murray Hill Nj 07974.

Discussions on Judith A Reinsdorf

No discussions yet.